Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting

Curcumin lozenges (each containing 100 mg of curcumin) will be given at a dose of 4 lozenges (total dose 400 mg curcumin) BD. Formulation is Solid Lipid Curcumin Particle (SLCP). Oral curcumin lozenges will be given from two days prior to receiving high dose chemotherapy till day+28 of transplant.

Placebo lozenges will be given from two days prior to receiving high dose chemotherapy till day+28 of transplant.